Listed by the USPTO as TURKOWSKI, KAYLA MARIE
Tech Center 4100 • Art Units: 3783 4100
This examiner grants 68% of resolved cases
TURKOWSKI, KAYLA MARIE is assigned to USPTO technology center 4100 and art unit 3783. The profile covers 81 resolved cases, with a 67.9% allowance rate and a 50.4% interview lift. Median time to allowance is 1456 days, while the limited case volume calls for care when applying the results to a broader portfolio.
Top company entries are Becton, Dickinson and Company, Sanofi S.A., and Novo Nordisk A/S. The listed firms are Bond, Schoeneck & King, PLLC - SANOFI, Christensen, Fonder, Dardi & Busse PLLC, and HARNESS DICKEY (DETROIT). The profile supports examiner-specific planning, particularly around interviews.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18736357 | Catheters, Catheter Assemblies, and Methods for Mechanically Inhibiting Formation of Occlusions | Non-Final OA | Bard Access Systems, Inc. |
| 18832669 | INGESTIBLE DEVICE WITH DETACHMENT OF TISSUE PENETRATING MEMBER | Non-Final OA | Novo Nordisk A/S |
| 17944109 | DUAL CHANNEL INFUSION PUMP FOR CONTINUOUS INFUSION | Final Rejection | CareFusion 303, Inc. |
| 18694777 | System, Method, and Computer Program Product for Vascular Access Management | Non-Final OA | Becton, Dickinson and Company |
| 18567616 | MEDICATION DELIVERY SYSTEM, PATCH PUMP AND MEDICAMENT DELIVERY DEVICE | Non-Final OA | Becton, Dickinson and Company |
| 18383628 | Safety Device for Mounting Onto a Drug Delivery Device | Non-Final OA | Becton, Dickinson and Company |
| 17274049 | UNIVERSAL SMART CAP FOR PEN INJECTORS | Non-Final OA | Becton, Dickinson and Company |
| 18431836 | DRUG DELIVERY SYSTEM | Non-Final OA | Analog Devices, Inc. |
| 18962038 | CARTRIDGE ASSEMBLY AND METHOD FOR ASSEMBLING THE SAME | Final Rejection | Sanofi |
| 18690328 | Encoder Ring, Dose Recording System and Drug Delivery Device Herewith | Non-Final OA | Sanofi |
| 18494353 | Injector Device | Final Rejection | Sanofi |
| 17607581 | Rotation Sensing Arrangement for an Injection Device | Non-Final OA | Sanofi |
| 18690245 | Side Access for Dual Lumen Ports | Non-Final OA | Bard Peripheral Vascular, Inc. |
| 18703363 | CLOSED-LOOP ARTIFICIAL PANCREAS INSULIN INFUSION CONTROL SYSTEM | Non-Final OA | MEDTRUM TECHNOLOGIES INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy67.9% of resolved applications examined by Kayla Marie Turkowski were allowed (81 resolved cases), compared with 67.3% across Art Unit 3783 over the last five years.
This examiner's interview lift is +50.4 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Kayla Marie Turkowski took 1,456 days on average from filing to allowance.
Kayla Marie Turkowski examines applications in Art Unit 3783 in Tech Center 4100.
